Conference Reports for NATAP

EASL - European Association for the Study of the Liver Barcelona, Spain May 27-30, 2026 Back

Semaglutide shows favourable safety across subgroups and a reassuring hepatic safety profile: Findings from ESSENCE Part 1       EASL 2026 May 26-30 Barcelona   Philip N. Newsome1,2,